Clinical Trials Logo

Lymphedema clinical trials

View clinical trials related to Lymphedema.

Filter by:

NCT ID: NCT02550951 Enrolling by invitation - Lymphedema Clinical Trials

Utility of MR Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy

Start date: October 2014
Phase: N/A
Study type: Interventional

Its usefulness in implementing magnetic resonance angiography for postoperative follow-up of lymph lymphedema should try to evaluate and compare lymphoscintigraphy.

NCT ID: NCT02528539 Completed - Lymphedema Clinical Trials

Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)

Start date: August 2013
Phase: N/A
Study type: Interventional

Introduction: Breast cancer women who are treated with axillary node dissection are at increased risk for lymphedema - the lifetime risk in these women is estimated at 15-50% and the risk can significantly increase with chemotherapy and radiation therapy Objectives: 1. To evaluate the feasibility and effectiveness of implementing the integrative therapy program (ITP) intervention. ITP consists of self-management education in conjunction with acupuncture. 2. To determine if ITP affects quality of life, self-efficacy, lymphedema knowledge, pain, and early detection and management of lymphedema. Design: the exploratory study aims to evaluate the feasibility and benefits of the integrative therapy program (ITP) intervention post-operatively for 18 months. Subjects: Women with breast cancer treated with axillary node dissection with normal baseline pre-operative bioimpedance (L-dex U400) score. Sample size: 30 subjects

NCT ID: NCT02527889 Completed - Breast Cancer Clinical Trials

The Effect of Resistive Exercise on Forearm Blood Flow and Tissue Oxygenation Among Breast Cancer Survivors With or at Risk for Breast Cancer-related Lymphoedema (BCRL)

Start date: July 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effect of resistive exercise on forearm blood flow and tissue oxygenation among breast cancer survivors with or at risk for breast cancer-related lymphoedema (BCRL).

NCT ID: NCT02518477 Completed - Breast Neoplasms Clinical Trials

Preventive Intervention Against Lymphedema After Breast Cancer Surgery

LYCA
Start date: September 2015
Phase: N/A
Study type: Interventional

This study will examine whether lymphedema after breast cancer surgery can be reduced. In a randomised controlled design the aim is to investigate whether an early intervention with progressive resistance training and close monitoring of arm swelling can reduce the incidence of lymphedema after breast cancer surgery.

NCT ID: NCT02517086 Not yet recruiting - Breast Cancer Clinical Trials

Vascular Changes Due to Different Treatments of Lymphedema Secondary to Postoperative Breast Cancer

Start date: August 2015
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the effect of elastic compression, functional compressive bandaging (ECF) and active exercises in the bloodstream of the upper member ipsilateral to the surgical procedure for the treatment of breast cancer.

NCT ID: NCT02506530 Completed - Lymphedema Clinical Trials

Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema

ELOCS
Start date: September 2015
Phase: N/A
Study type: Interventional

This study will assess the benefit of LPG Cellu M6 in addition of intensive decongestive treatment in reducing secondary lymphoedema in breast cancer.

NCT ID: NCT02496013 Recruiting - Lymphedema Clinical Trials

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

Start date: January 2014
Phase: Phase 1
Study type: Interventional

This is an open-label whole-body PET/CT study for investigation of radiation dosimetry, plasma pharmacokinetics, biodistribution, safety and diagnostic performance of 68Ga-NEB in healthy volunteers and patients with suspected infection. Changes of routine blood and urine tests and any adverse events will be collected from the volunteers. Adverse events will also be observed in the patients.

NCT ID: NCT02494206 Completed - Breast Cancer Clinical Trials

Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)

Start date: July 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of QBX258, a compound developed by Novartis Corporation composed of two antibodies, in reducing arm volume excess in women with stage I-II breast cancer related lymphedema.

NCT ID: NCT02494115 Completed - Lymphedema Clinical Trials

Comfort Subcutaneous Drainage: a Descriptive Study Among Palliative Phase Cancer Patients

Start date: January 6, 2016
Phase: N/A
Study type: Interventional

Physical embarrassment, pain and psychological impact linked to the body image distortion are often associated to these lymphedemas. Investigators decided to study new therapeutic method because of major discomfort due to these oedemas and doctors' difficulty to manage them. Subcutaneous drainage also called lymphocentesis seems to be an interesting technique. This local treatment consists in inserting in lower limbs several catheters draining into enclosed bags in order to evacuate lymph fluid and to lower local pressure. Very few studies have been published concerning this technique and are presenting only a small number of cases. They cannot allow clear conclusions of this technique's efficiency but show encouraging results. Investigators want to collect more data on this technique using a larger number of subjects in order to evaluate subcutaneous drainage effects on the comfort of palliative care cancer patients presenting lower limbs lymphedema. Investigators will consider as lymphedema, oedemas with no renal or cardiovascular identified cause and excluding anasarca.

NCT ID: NCT02476357 Completed - Lymphoedema Clinical Trials

A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection

Start date: January 2009
Phase: N/A
Study type: Interventional

Patients undergoing groin or axillary Radical lymph node dissection (RLND) or completion lymph node dissection (CLND, after positive sentinel lymph node biopsy (SLNB) for melanoma or breast cancer were randomized in a controlled trial for surgical dissection technique. Harmonic scalpel dissection were compared with classic dissection in term of lymphocoele and oedema.